Omeros suspends mid-stage trial of Huntington's drug, shares fall
October 21, 2014 at 08:23 AM EDT
Oct 21 (Reuters) - Omeros Corp said it suspended enrolment in a mid-stage study testing its experimental Huntington's drug as the company evaluates data from a concurrent trial in rats, sending its shares down 10 percent before the bell.
